Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients

by Shih-Jer Hsu, Sukhee Enkhzaya, You-Yu Lin, Tai-Chung Tseng, Tulgaa Khosbayar, Cheng-Hsueh Tsai, Tzu-San Wang, Damba Enkhtuya, Dogsom Ivshinkhorol, Nyamsuren Naranzul, Badarch Jargalsaikhan, Jazag Amarsanaa, Oidov Baatarkhuu, Jia-Horng Kao
Published 2020-03-01